Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             91 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 EDITORIAL BOARD
29 S1 p.
artikel
2 O-7 CURRENT PRACTICE OF LIVER TRANSPLANTATION IN LATIN AMERICAN COUNTRIES: AN ALEH INTEREST GROUP SURVEY 2023 Bittencourt, Paulo

29 S1 p.
artikel
3 O-3 DEVELOPMENT OF LENTIVIRAL VECTORS FOR INHIBITION OF HEPATITIS B VIRUS VIA SMALL INTERFERING RNA Lago, Barbara

29 S1 p.
artikel
4 O-18 DIFFERENCES IN BODY COMPOSITION OF MAFLD PATIENTS ACCORDING TO BODY MASS INDEX AND METABOLIC PROFILE Juárez, Eva

29 S1 p.
artikel
5 O-16 DIFFERENCES IN HEPATOCARCINOMA IN PATIENTS WITH CIRRHOSIS DUE TO NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) VS. OTHER ETIOLOGIES Sanga, Jimmy

29 S1 p.
artikel
6 O-20 EFFECTS OF ISOCALORIC AND NEGATIVE CALORIE BALANCE EXERCISE ON SERUM LEVELS OF INSULIN-LIKE GROWTH FACTOR TYPE 1 IN SUBJECTS WITH INITIAL AND ADVANCED FATTY LIVER Fuenzalida, María Jesús

29 S1 p.
artikel
7 O-22 EFFICACY OF ATEZOLIZUMAB BEVACIZUMAB TREATMENT FOR HEPATOCELLULAR CARCINOMA IN REAL-WORLD CLINICAL PRACTICE AT TWO TERTIARY HEALTHCARE CENTERS IN SOUTHERN BRASIL: FIRST INTERIM ANALYSIS Cheinquer, Hugo

29 S1 p.
artikel
8 O-11 ENHANCEMENT OF F4/80+CD11B-CD206+ KUPFFER CELLS IN LIVER TISSUE: EFFECT OF MARESIN-1 AS HEPATOPROTECTIVE AGENT Zuñiga, Jessica

29 S1 p.
artikel
9 O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION Araujo, Alexandre

29 S1 p.
artikel
10 O-6 EXPLORING THE IMPACT OF INFECTIONS IN PATIENTS WITH ALCOHOL- ASSOCIATED HEPATITIS IN LATIN AMERICA Díaz, Luis Antonio

29 S1 p.
artikel
11 O- 5 HCC RISK SCORE PRE AND POST SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED FOR CHRONIC HEPATITIS C Gomes, Marcus Vinícius de Acevedo Garcia

29 S1 p.
artikel
12 O-12 HELICOBACTER PYLORI VIRULENCE GENES ARE ASSOCIATED WITH NAFLD SEVERITY: A CROSS SECTIONAL STUDY IN DYSPEPTIC PATIENTS Maiorana, Facundo

29 S1 p.
artikel
13 O-19 IMPLICATIONS OF GLYPHOSATE ON NON-ALCOHOLIC FATTY LIVER DISEASE IN MICE Romualdo, Guilherme

29 S1 p.
artikel
14 O-15 MARESIN1 REVERSES CHRONIC LIVER FIBROSIS AND IMPROVES REGENERATION Herrera, Francisca

29 S1 p.
artikel
15 O-4 MBOAT7 RS641738 IS ASSOCIATED WITH PROGRESSION TO CIRRHOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN LATIN AMERICA Goble, Spencer

29 S1 p.
artikel
16 O-14 NON-ALCOHOLIC FATTY LIVER DISEASE IS INFLUENCED BY THE INTERACTION OF HELICOBACTER PYLORI INFECTION AND G-ALLELE OF PNPLA3 Maiorana, Facundo

29 S1 p.
artikel
17 O-17 NUTRICIONAL AND PHYSICAL THERAPHY IMPROVES LIVER FRAILTY INDEX IN LISTED PATIENTS WITH CIRRHOSIS: RANDOMIZED CONTROLLED TRIAL. INTERIM ANALYSIS Reyes, Diego

29 S1 p.
artikel
18 O-21 NUTRITIONAL SUPPLEMENTATION WITH MEXICAN FOODS, OPUNTIA FICUS INDICA, THEOBROMA CACAO, AND ACHETA DOMESTICUS IMPROVED GUT-LIVER AXIS IN A MAFLD MICE MODEL. Rosas, Rebeca

29 S1 p.
artikel
19 OP-2 ANALYSIS OF THE GENETIC DIVERSITY OF HEPATITIS DELTA VIRUS CIRCULATING IN BRAZIL BETWEEN 2013 AND 2021 AND ITS RELATIONSHIP WITH HEPATITIS B VIRUS Angelice, Giovana

29 S1 p.
artikel
20 OP-4 DEVELOPMENT AND EXTERNAL VALIDATION OF A MODEL TO PREDICT MULTI-DRUG RESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS Marciano, Sebastian

29 S1 p.
artikel
21 OP-1 FEATURES OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN LATIN AMERICA: LONG-TERM EXPERIENCE OF THE LATINDILI NETWORK Bessone, Fernando

29 S1 p.
artikel
22 OP-3 HCV MICROELIMINATION PROGRAM IN HEMODIALYSIS PATIENTS: SUCCESS OF A MULTI-STAKEHOLDER PARTNERSHIP BASED ON A NATIONAL ERADICATION STRATEGY Ridruejo, Ezequiel

29 S1 p.
artikel
23 O- 8 PNPLA3 RS738409 C>G POLYMORPHISM IMPACT ON HCV-RELATED HCC DEVELOPMENT IN THE BRAZILIAN POPULATION: PRELIMINARY RESULTS Maccali, Claudia

29 S1 p.
artikel
24 O-9 PRESENCE OF METABOLIC ASSOCIATED LIVER DISEASE IN AUTOIMMUNE HEPATITIS IS ASSOCIATED WITH ADVANCED LIVER FIBROSIS Arévalo, Giselle

29 S1 p.
artikel
25 O-1 SEROPREVALENCE AND MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B AND C VIRUSES AMONG PREGNANT WOMEN IN A MATERNAL AND CHILDREN HOSPITAL FROM THE PROVINCE OF BUENOS AIRES Solis, Rosana

29 S1 p.
artikel
26 O- 23 STRATEGIES TO ELIMINATE HEPATITIS C VIRUS INFECTION IN THE AMERICAS Díaz, Luis Antonio

29 S1 p.
artikel
27 O-13 SUB-OPTIMAL GLOBAL PUBLIC HEALTH POLICIES AND STRATEGIES TO TACKLE HEPATOCELLULAR CARCINOMA Díaz, Luis Antonio

29 S1 p.
artikel
28 O-10 VALIDATION OF SERUM BIOMARKER PANELS FOR EARLY HCC DETECTION: RESULTS FROM A LARGE PROSPECTIVE LATIN AMERICAN MULTICENTER STUDY Beudeker, Boris

29 S1 p.
artikel
29 P- 47 ACCURACY OF MAFLD-S SCORE TO DIAGNOSE HEPATIC STEATOSIS IN A GROUP OF APPARENTLY HEALTHY PEOPLE. Chávez, Luis Carlos

29 S1 p.
artikel
30 P- 55 ACUTE LIVER FAILURE IN PERU: EPIDEMIOLOGY AND PROBLEMATIC OF SUPPORT AND MANAGEMENT Padilla, P. Martin

29 S1 p.
artikel
31 P- 36 ACUTE ON CHRONIC LIVER FAILURE IN LATIN AMERICA: SUB-ANALYSIS OF A SYSTEMATIC REVIEW AND META-ANALYSIS Mezzano, Gabriel

29 S1 p.
artikel
32 P- 46 AMOUNT OF DIETETIC FAT AND CARBOHYDRATE TYPES RELATED TO HEPATIC STEATOSIS IN A GROUP OF MEXICAN ADULTS Martínez, Sophia Eugenia

29 S1 p.
artikel
33 P- 18 ANASTROZOLE MAY NOT BE ASSOCIATED FATTY LIVER DISEASE AND HEPATIC FIBROSIS IN WOMEN WITH BREAST CANCER Jorge, Mateus

29 S1 p.
artikel
34 P-5 APACHE STUDY DESIGN TO EVALUATE THE EFFICACY AND SAFETY OF PLASMA EXCHANGE WITH HUMAN SERUM ALBUMIN 5% ON SHORT-TERM SURVIVAL IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE AT HIGH RISK OF HOSPITAL MORTALITY. Pyrsopoulos, Nikolaos

29 S1 p.
artikel
35 P-9 AUTOIMMUNE LIVER DISEASES IN LATIN AMERICA: A WEB-BASED SURVEY Alves, Claudia

29 S1 p.
artikel
36 P-57 CHARACTERIZATION OF HEPATOCELLULAR CARCINOMA AND ITS RELATIONSHIP WITH ALPHA-FETOPROTEIN LEVELS Beltran, Mayra Fernanda

29 S1 p.
artikel
37 P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY Idalsoaga, Francisco

29 S1 p.
artikel
38 P- 37 CLINICAL EVOLUTION OF PATIENTS WITH AUTOIMMUNE LIVER DISEASES IN A LIVER TRANSPLANTATION CENTER Rodríguez, Harlim

29 S1 p.
artikel
39 P- 58 CLINICAL OUTCOMES OF PATIENTS WITH GRAFT REJECTION FOLLOWING TRANSPLANTATION FOR AUTOIMMUNE LIVER DISEASE AT A LIVER TRANSPLANT CENTER IN COLOMBIA Morales, Ximena

29 S1 p.
artikel
40 P- 35 COMPLICATIONS ASSOCIATED TO THE LIVER TRANSPLANTATION IN PATIENTS WITH CIRRHOTIC CARDIOMYOPATHY Ruiz, José Ignacio

29 S1 p.
artikel
41 P- 52 CORRELATION AMONG DIFFERENT METHODS TO ESTIMATE BODY AND LIVER FAT IN HEALTHY ADULTS Martínez, Sophia Eugenia

29 S1 p.
artikel
42 P- 49 DECOMPETATIONS CAUSING ADMISSION, READMISSION AND MORTALITY IN CIRRHOTIC PATIENTS ADMITTED AT EUGENIO ESPEJO SPECIALTY HOSPITAL. QUITO, ECUADOR Waldroph, Walkenys Abigail

29 S1 p.
artikel
43 P-27 DESCRIPTIVE STUDY ON PATIENTS WITH HEPATOCARCINOMA IN A PUBLIC HOSPITAL 2018-2023 Huerta, Paula Andrea

29 S1 p.
artikel
44 P-60 DIAGNOSTIC PERFORMANCE OF FIBROSCAN FOR LIVER DISEASE IN BOGOTA, COLOMBIA Torres, Diana Del Pilar

29 S1 p.
artikel
45 P- 24 DISTRIBUTION OF HEPATITIS C GENOTYPES IN THE ARGENTINE POPULATION IN THE LAST TEN YEARS Sfalcin, Javier Alejandro

29 S1 p.
artikel
46 P- 61 DRUG-INDUCED LIVER INJURY: REPORTING CHALLENGES AND ENZYMATIC CHANGES IN PATIENTS USING ANTIBIOTICS – RETROSPECTIVE STUDY Suarez, Nelson David

29 S1 p.
artikel
47 P-1 EFFECTIVENESS AND SAFETY OF BARIATRIC SURGERY IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS SECONDARY TO METABOLIC ASSOCIATED FATTY LIVER DISEASE IN A TERTIARY REFERENCE HOSPITAL Reis, Ana Luiza Gomes

29 S1 p.
artikel
48 P- 48 EFFECT OF THE COMBINATION OF ORLISTAT AND L-CARNITINE ON THE QUALITY OF LIFE (SF.36) IN 16 OVERWEIGTH PATIENTS Carmona, Miguel Yael

29 S1 p.
artikel
49 P-54 EVALUATION OF DAILY CLINICAL PRACTICE IN A CENTRAL AMERICAN COHORT WITH A DIAGNOSIS OF AUTOIMMUNE LIVER DISEASE: THEORY VS. PRACTICE Ochoa, Alejandra

29 S1 p.
artikel
50 P-45 EVALUATION OF THE ALBI SCORE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH YTTRIUM-90 (90Y) Cornejo, Stefanny

29 S1 p.
artikel
51 P-21 FIBROSIS DEVELOPMENT AND MALIGNANCIES ARE DELAYED BY PIRFENIDONE WHILE INCREASING SIRT1 NUCLEAR TRANSLOCATION AND HISTONE 3 DEACETYLATIONS IN A HEPATOCARCINOMA MODEL Monroy, Hugo Christian

29 S1 p.
artikel
52 P- 26 FIBROSIS FREQUENCY IN A COHORT OF METABOLIC FATTY LIVER DISEASE RISK PATIENTS Flores, Priscila

29 S1 p.
artikel
53 P- 33 FREQUENCY, PROPHYLAXIS AND MANAGEMENT OF VARICEAL BLEEDING IN PATIENTS WITH LIVER CIRRHOSIS IN A RETROSPECTIVE MULTICENTER COHORT FROM SOUTH AMERICA Balderramo, Domingo

29 S1 p.
artikel
54 P- 43 HCV TESTING AND TREATMENT IN FOUR BRAZILIANS’ CORRECTIONAL SETTINGS da Silva, Joao Batista

29 S1 p.
artikel
55 P-15 HELICOBACTER PYLORI AS A RISK FACTOR FOR THE DEVELOPMENT OF MANIFEST ENCEPHALOPATHY AND OTHER COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS AT THE EUGENIO ESPEJO HOSPITAL IN THE PERIOD MAY 2019-JUNE 2022 Orozco, Mariana Gabriela

29 S1 p.
artikel
56 P- 38 HEPATITIS E VIRUS IN PATIENTS WITH CHRONIC LIVER DISEASE IN COLOMBIA Prieto, Jhon Edison

29 S1 p.
artikel
57 P- 16 HEPATOCELLULAR CARCINOMA IN CENTRAL AMERICA: A MULTIDISCIPLINARY APPROACH IN A COSTA RICAN COHORT Castro, María

29 S1 p.
artikel
58 P- 23 HEPATOCELLULAR CARCINOMA IN CENTRAL AMERICA: EPIDEMIOLOGY OF A COSTA RICAN COHORT Vargas, Francisco

29 S1 p.
artikel
59 P-28 HEPATOTOXICITY OF PESTICIDES USED IN VITICULTURES IN THE SOUTHERN BRAZIL REGION Suarez, Nelson David

29 S1 p.
artikel
60 P-4 HETEROGENEITY OF PRE-LIVER TRANSPLANT EVALUATION PRACTICES IN LATIN AMERICA COUNTRIES: THE LIVER TRANSPLANT ALEH SPECIAL INTEREST GROUP, INTERNATIONAL SURVEY 2023 Mainardi, Victoria

29 S1 p.
artikel
61 P-41 IMPACT OF CHOLEMIC NEPHROSIS ON RENAL FAILURE IN CIRRHOTIC PATIENTS Lozada, Silvia Johanna

29 S1 p.
artikel
62 P- 30 IMPACT OF SELF-REPORTED ANCESTRY IN HEPATOCELLULAR CARCINOMA IN HISPANIC POPULATIONS Goble, Spencer

29 S1 p.
artikel
63 P-13 IMPACT OF SPONTANEOUS BACTERIAL PERITONITIS ON THE OUTCOME OF PATIENTS WITH HEPATIC CIRRHOSIS Teutli, Sandra

29 S1 p.
artikel
64 P-29 INCIDENCE AND ASSOCIATED FACTORS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION IN A SINGLE CENTER IN PERU: A RETROSPECTIVE STUDY. Campos, Williams Celedonio

29 S1 p.
artikel
65 P- 17 LIVER TESTS ABNORMALITIES AS PROGNOSTIC MARKERS OF DEATH IN PATIENTS HOSPITALISED BY COVID-19. A COHORT STUDY Rodriguez-Gutierrez, Andrés Fernando

29 S1 p.
artikel
66 P-12 MELD 3.0 IS THE BEST PREDICTOR OF MORTALITY IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) Medina-Avalos, Ernesto Javier

29 S1 p.
artikel
67 P- 42 METABOLIC ASSOCIATED FATTY LIVER DISEASE AND BODY COMPOSITION MEASUREMENT Nogueira, Maria Auxiliadora

29 S1 p.
artikel
68 P- 25 METABOLIC, HISTOLOGICAL AND INFLAMMATORY BENEFITS IN A MURINE MODEL OF ALCOHOLIC STEATOHEPATITIS USING METHYL-GROUP DONOR SUPPLEMENTATION Diaz, Carolina

29 S1 p.
artikel
69 P-31 METHOTREXATE SEEMS NOT TO BE ASSOCIATED WITH LIVER FIBROSIS IN RHEUMATOID ARTHRITIS PATIENTS De Araújo, Leandro Augusto

29 S1 p.
artikel
70 P- 39 N-ACETYL CYSTEINE ATTENUATES ALTERATIONS GENERATED IN EXPERIMENTAL LIVER STEATOSIS INDUCED BY CHRONIC ALCOHOL CONSUMPTION PLUS A HYPERCALORIC DIET Galicia, Marina

29 S1 p.
artikel
71 P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST. Rodríguez, Samael

29 S1 p.
artikel
72 P- 53 NATURAL KILLER CELLS OF EARLY STAGES OF METABOLIC FATTY LIVER DISEASE PRESENT REDUCED CYTOTOXICITY AGAINST TUMOR CELLS. CASE- CONTROL ANALYSIS Olivares, Nixa Paola

29 S1 p.
artikel
73 P-8 OSTEOSARCOPENIA AND FIBROSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE Soares, Débora

29 S1 p.
artikel
74 P-44 OUTCOMES AND MORTALITY OF PATIENTS WITH HEPATOPULMONARY SYNDROME AT A QUATERNARY LIVER TRANSPLANT CENTER Gomes, Marcus Vinícius De Acevedo Garcia

29 S1 p.
artikel
75 P-20 OXIDATIVE STRESS MARKERS IN ALCOHOLIC LIVER DISEASE GUTIÉRREZ, GABRIELA

29 S1 p.
artikel
76 P- 40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY Idalsoaga, Francisco

29 S1 p.
artikel
77 P-3 PIRFENIDONE PREVENTS OBESITY-ASSOCIATED NONALCOHOLIC STEATOHEPATITIS AND CARDIAC FIBROSIS THROUGH HORMONAL REPROGRAMMING Gutiérrez, Jorge

29 S1 p.
artikel
78 P-6 PREVALENCE AND CLINICAL CHARACTERISTICS OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE IN MÉXICO Jasso, Erick Augusto

29 S1 p.
artikel
79 P-11 PRIMARY BILIARY CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS HEPATIC OVERLAP SYNDROME – CASE REVIEW Aronsohn, Federico

29 S1 p.
artikel
80 P- 62 RELAPSE OF AUTOIMMUNITY IN PATIENTS WITH LIVER TRANSPLANTATION FOR AUTOIMMUNE HEPATOPATHY AT A COLOMBIAN HEPATOLOGY CENTER Morales, Ximena

29 S1 p.
artikel
81 P- 7 RISK FACTORS FOR NON-ALCOHOLIC FATTY LIVER DISEASE AFTER LIVER TRANSPLANTATION Arouca, Marcelo

29 S1 p.
artikel
82 P- 59 ROLE OF MARESINA-1 ON THE KIDNEY AND LIVER MORPHOLOGY ON A MURINE MODEL OF TYPE I DIABETES MELLITUS INDUCED WITH STREPTOZOTOCIN Morales, Pamela Carolina

29 S1 p.
artikel
83 P-51 SERUM MICRORNA EXPRESSION ACCORDING TO THE PRESENCE OF LIVER DISEASE AND SARS-CoV-2 INFECTION Da, Lucas Lima

29 S1 p.
artikel
84 P-14 SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS: PREVALENCE AND ANTIBIOTIC RESISTANCE PATTERNS Campos, Bruno

29 S1 p.
artikel
85 P-10 THE EFFECTS OF CHILEAN RESPONSE TO COVID-19 ON ALCOHOL CONSUMERS: A NATURAL POLICY EXPERIMENT Fuenzalida, María Jesús

29 S1 p.
artikel
86 P- 34 TOMOGRAPHIC ASSESMENT OF SARCOPENIA IN CIRRHOTIC PATIENTS BEFORE LIVER TRASPLANT: PREVALENCE, ASSOCIATED FACTORS AND POST-SURGERY OUTCOMES IN A COHORT OF CHILEAN PATIENTS Orellana, Kenia

29 S1 p.
artikel
87 P- 56 TUBERCULOSIS IN LIVER TRANSPLANT RECIPIENTS: EXPERIENCE OF A SINGLE CENTER Bertha, Cárdenas Ramírez

29 S1 p.
artikel
88 P-22 UNCOVERING INSIGHTS ON ACUTE VARICEAL HEMORRHAGE: A CROSS- COUNTRY SURVEY STUDY ON THE MANAGEMENT OF UPPER GASTROINTESTINAL BLEEDING IN LATIN AMERICA Ruiz, Jesus

29 S1 p.
artikel
89 P- 63 UTILITY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN TREATING COMPLICATIONS OF PORTAL HYPERTENSION: EXPERIENCE IN UNIT OF LIVER TRANSPLANTATION IN URUGUAY Rey, Romina

29 S1 p.
artikel
90 P- 32 VALIDATION OF LILLE-4 VERSUS LILLE-7 TO PREDICT SHORT-TERM MORTALITY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS Dorantes, Claudia Leticia

29 S1 p.
artikel
91 P- 50 VALIDATION OF S-ANT FOR THE DIAGNOSIS OF HEPATIC ENCEPHALOPATHY MINIMUM Perez, Jose Luis

29 S1 p.
artikel
                             91 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland